Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.81 | 1.42 |
NAV | ₹103.61 | ₹1858.42 |
Fund Started | 31 Jul 2008 | 08 Dec 1994 |
Fund Size | ₹5012.19 Cr | ₹66304.16 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 34.54% | 25.41% |
3 Year | 26.97% | 24.73% |
5 Year | 24.16% | 22.66% |
1 Year
3 Year
5 Year
Equity | 98.93% | 87.35% |
Cash | 1.07% | 11.88% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.27% |
ICICI Bank Ltd. | 4.98% |
Infosys Ltd. | 4.38% |
State Bank of India | 4.23% |
Bharti Airtel Ltd. | 3.42% |
Tech Mahindra Ltd. | 2.74% |
Larsen & Toubro Ltd. | 2.72% |
Dr. Reddy's Laboratories Ltd. | 2.45% |
Biocon Ltd. | 2.40% |
Samvardhana Motherson International Ltd. | 2.36% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.75% |
ICICI Bank Ltd. | 9.71% |
Axis Bank Ltd. | 8.23% |
Cipla Ltd. | 4.44% |
Kotak Mahindra Bank Ltd. | 4.39% |
Maruti Suzuki India Ltd. | 4.18% |
SBI Life Insurance Company Ltd. | 4.07% |
Bharti Airtel Ltd. | 4.01% |
HCL Technologies Ltd. | 3.90% |
Piramal Pharma Ltd. | 2.94% |
Name | Satish Ramanathan | Dhruv Muchhal |
Start Date | 01 Oct 2024 | 14 Sep 2023 |
Name
Start Date
Description | The scheme which aims to provide capital appreciation by investing primarily in equity and equity related securities of various market depending upon valuation discount or premium amongst Large / Mid & Small cap stocks, the fund will keep varying the weights to capture the value while keeping an optimum Risk / Return profile. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 31 Jul 2008 | 08 Dec 1994 |
Description
Launch Date